Global Blood Therapeutics Email Format
Biotechnology ResearchCalifornia, United States201-500 Employees
Global Blood Therapeutics (GBT) is now part of Pfizer, and we look forward to continuing our mission on behalf of people living with sickle cell disease. The Global Blood Therapeutics page will no longer be active or monitored. Please follow Pfizer for new content.